INTRODUCTION
The innate immune recognition is mediated by a structurally diverse set of receptors that belong to several distinct protein families. Among them are humoral proteins circulating in the plasma, endocytic receptors expressed on the cell surface, and signalling receptors including Toll-like receptors (TLRs). 1 TLRs are type I transmembrane proteins that are grouped into the same gene family based on their sequence similarity. [2] [3] [4] [5] All show peculiar structural features. Several leucine rich repeats (LRR) are present in the extracellular domain of the molecule; similar tandem arrays of LRR commonly form the adhesive antennae of varied cell surface molecules. TLRs cross the cytoplasmic membrane once, and their intracellular portion is extremely similar to the cytoplasmic domain of both the Drosophila Toll and the IL-1 receptor (IL-1R); [6] [7] [8] this may suggest an analogous molecular framework for signalling.
Even though a specific ligand for Drosophila Toll receptor has been proposed based on genetic analysis (namely Spaetzle), no Spaetzle homologue has been identified in vertebrates yet; in this respect, human TLRs are still orphan receptors. 9 On the other hand, several microbial molecules have been found to specifically activate TLRs thus acting as 'opportunistic ligands/activators'. [10] [11] [12] [13] [14] [15] [16] [17] [18] However, it has also been hypothesized that an endogenous protein will also specifically bind and activate TLRs; it has been recently suggested that the LRR region of TLR may retain an affinity for Spaetzle-related cysteine-knot factors; candidate TLR ligands are expected to fit this model. 3 Notably, an extracellular protein, MD-2, has been shown to bind TLR4 and to confer LPS responsiveness. The presence of MD-2 appears to be an essential prerequisite for TLR4 signalling. However, a canonical cytokine-like TLR4 ligand is still missing. 19 TLR4 has been genetically identified as an essential and non-redundant component of the LPS receptor signalling complex that controls innate immune responses in vivo. 10, 17, 20 Other groups have recently suggested that another member of the TLR family, namely TLR2, can provide LPS responsiveness to insensitive cell lines; 11, 12 in fact, it has been recently shown that TLR2 can restore cells' responsiveness to peptidoglycans and lipoteichoic acids. 14 Recent evidence, based on the analysis of TLR4-deficient mice, demonstrates that TLR4 may be more specifically involved in LPS signalling. 17 On the other hand a study of TLR2 deficient mice showed that TLR2 specifically confers responsiveness to several Gram-positive bacterial cell
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Toll is a Drosophila gene essential for ontogenesis and antimicrobial resistance. Several homologues of Toll have been identified and cloned in vertebrates, namely Toll-like receptors (TLRs). TLRs are structurally characterized by a cytoplasmic Toll/interleukin-1R (TIR) domain and by extracellular leucine rich repeats. TLRs characterized so far activate the MyD88/IRAK signalling cascade which activates NF-κB transcription factor. Genetic, gene transfer, and dominant negative approaches have involved TLR family members (TLR2 and TLR4) in distinct bacterial components for recognition and signalling. However, very little information is available regarding other TLRs. Here we propose to classify TLRs based on their expression pattern, in ubiquitous (TLR1), restricted (TLR2, 4, 5) and specific (TLR3) TLRs. Differential expression and regulation as well as distinct, though overlapping, ligand recognition patterns may underlie the existence of a such a large, seemingly redundant, TLR family.
walls, such as Staphylococcus aureus, peptidoglycans and zymosan. 17, 18 Despite the assumption that TLRs mediate innate immune response, no data are available regarding their expression pattern in immunocompetent cells.
MATERIALS AND METHODS
Cell culture
The cell culture medium routinely used was RPMI 1640 with 2 mM glutamine and 10% FCS (complete medium). All reagents contained less then 0.125 EU/ml of endotoxin as checked by Limulus amebocyte lysate assay (Microbiological Associates, Walkersville, MD, USA). Circulating human monocytes, polymorphonuclear cells (PMN), lymphocytes and natural killer (NK) cells were separated from blood of normal donors (>95% pure as assessed by morphology) by Percoll (Pharmacia, Uppsala, Sweden) gradient centrifugation. Dendritic cells were obtained and maturated in vitro from precursor monocytes. Th1 and Th2 cells were a kind gift of Dr D. D'Ambrosio (Roche Milano Ricerche). Large and small B lymphocytes were a kind gift of Dr J. Golay (Mario Negri Institute). After the appropriate treatment, cells were examined for TLR mRNA as detailed below.
Northern blot analysis
Total RNA was isolated by the guanidine isothiocyanate method with minor modifications. Total RNA (8 µg) was analysed by electrophoresis through 1% agarose/formaldehyde gels, followed by Northern blot transfer to Gene Screen Plus membranes (New England Nuclear, Boston, MA, USA). The plasmids containing human TLR cDNAs were labelled with α-[ 32 P]-dCTP (3000 Ci/mmol; Amersham, Buckinghamshire, UK). Membranes were pre-treated and hybridised in 50% formamide (Merk, Rahway, NJ, USA) with 10% dextran sulphate (Sigma) and washed twice with 2 x SSC (1 x SSC; 0.15 M NaCl; 0.015 M sodium citrate) and 1% sodium dodecyl sulphate (SDS; Merk) at 60°C for 30 min, and finally washed twice with 0.1 x SSC at room temperature for 30 min. Membranes were exposed for 4-48 h at -80°C with intensifying screens. RNA transfer to membranes was checked by UV irradiation.
RESULTS AND DISCUSSION
TLR4 signalling pathway
In our own studies, based on our previous efforts on IL-1, we investigated the signalling pathway activated by TLR4. TLR4 shares sequence similarity with distinct members of the IL-1R family including IL-1RI, IL-1RAcP and MyD88; of note, Phe 513 and Trp 514 in IL-1RI, that are conserved in all these proteins, have been shown to be essential for IL-1RI signalling. In fact, TLR4 activates the MyD88 signalling pathway, initially identified for IL-1R. 21, 22 Indeed, LPS activates the MyD88/IRAK signalling cascade in monocytic and in endothelial cells. 13, 20 Available information suggests that a stereotyped signalling response is activated by different TLR family members (Fig. 1) .
The functional involvement of downstream mediators of the TLR4 signalling pathway in LPS-induced cell activation has been genetically confirmed by the creation of MyD88 and TRAF6 deficient mice. 23, 24 It has been demonstrated that these molecules are essential for LPS responsiveness in vivo; however, even though in vitro experiments showed that MyD88 mediates NF-κB induction, MyD88deficient mice show only a partial deficient phenotype regarding the LPS-induced activation of NF-κB suggesting that additional unknown mediators may also be involved in this pathway. 23 On the other hand, TRAF6 was shown to be necessary for both NF-κB and c-Jun activation in vivo despite the fact that a dominant negative version of it did not block TLR4-induced c-Jun activation in vitro. 24 
TLR expression pattern
Despite the assumption that TLRs mediate innate immune response, no data are available regarding their expression pattern in immunocompetent cells. There are many members of the TLR family; 6 have been characterised, 2-5 and other partial cDNA sequences are deposited in the databases. Their number may reflect specialised functions, redundancy and/or differential expression and roles in different cell types. We have designed a study to systematically characterise the pattern of expression of the first 5 TLRs at the level of mRNA. The results obtained demonstrate differential expression and regulation of TLR and suggest a novel classification of these molecules.
We separated fresh human monocytes, T cells, NK cells and polymorphonuclear granulocytes (PMN), B lymphocytes, Th1 or Th2 lymphocytes, and dendritic cells (DC). Total RNA was extracted from the cells and analysed by Northern blot to detect specific TLR transcripts. TLR1 mRNA is ubiquitously expressed. In contrast, TLR2 to TLR5 show a restricted pattern of expression; in particular, TLR2, TLR4 and TLR5 are present in monocytes, PMN and DC. Of note, TLR3 is exclusively expressed by DC, but absent in all the other leukocytes analyzed (see Table 1 for a schematic representation). 25 Exposure to bacterial products, such as lipopolysaccharide (LPS), or to primary cytokines such as IFN-γ, increased TLR4 expression. In contrast, TLR2 was unaffected by LPS but increased by distinct Gram-positive bacterial components. All in all, these observations suggest that TLR4 and TLR2 expression can be differentially regulated at sites of infection or inflammation, either directly by bacterial components, or indirectly by primary cytokines. 25 After culture in the presence of GM-CSF, IL-4 or IL-13 for 7 days, precursor monocytes differentiate into DC. Upon an additional exposure to inflammatory signals (such as TNF-α, IL-1β or LPS), they undergo functional maturation. DCs are unique in that they have the whole repertoire of 5 characterised TLR receptors and are the only cell type that expresses appreciable levels of TLR3 mRNA. This full repertoire may reflect the unique role of DC in sensing pathogens and causing transition from innate to specific immunity. 25 Collectively, these observations suggest that it may be useful to classify TLRs based on their pattern of expression in ubiquitous (TLR1), restricted, (TLR2, TLR4 and TLR5), and specific (TLR3) molecules (Table 1) . 
